Literature DB >> 16965765

NF-kappaB activation by double-strand breaks.

Yvette Habraken1, Jacques Piette.   

Abstract

Cellular response to DNA damage is complex and relies on the simultaneous activation of different networks. It involves DNA damage recognition, repair, and induction of signalling cascades leading to cell cycle checkpoint activation, apoptosis, and stress related responses. The fate of damaged cells depends on the balance between pro- and antiapoptotic signals. In this decisive life or death choice, the transcription factor NF-kappaB has emerged as a prosurvival actor in most cell types. As corollary, it appears to be associated with tumorigenic process and resistance to therapeutic strategies as it protects cancerous cells from death. In this review, we will focus on NF-kappaB activation by double-strand breaks inducing agents, such as ionizing radiation and DNA topoisomerase I and II inhibitors routinely used in cancer therapy. Coinciding with the 20th anniversary of the NF-kappaB discovery, major steps of the DSB-triggered cascade have been recently identified. Two parallel cascades are necessary for NF-kappaB activation. The first one depends on ATM (activated by double-strand breaks) and the second on PIDD (activated by an unknown stress signal). The phosphorylation of NEMO by ATM is the point of convergence of these two cascades. The identification of ATM/NEMO complex as the long searched "nuclear to cytoplasm" signal leading to IKK activation is also a major piece of the puzzle. The knowledge of the precise steps leading to DSB-initiated NF-kappaB activation will allow the development of specific blocking compounds reducing its prosurvival function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965765     DOI: 10.1016/j.bcp.2006.07.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  53 in total

1.  Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression.

Authors:  Kei Sakamoto; Yohko Hikiba; Hayato Nakagawa; Yoku Hayakawa; Ayako Yanai; Masao Akanuma; Keiji Ogura; Yoshihiro Hirata; Klaus H Kaestner; Masao Omata; Shin Maeda
Journal:  Gastroenterology       Date:  2010-03-25       Impact factor: 22.682

Review 2.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 3.  DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.

Authors:  Claire Gourzones-Dmitriev; Alboukadel Kassambara; Surinder Sahota; Thierry Rème; Jérôme Moreaux; Pascal Bourquard; Dirk Hose; Philippe Pasero; Angelos Constantinou; Bernard Klein
Journal:  Cell Cycle       Date:  2013-08-09       Impact factor: 4.534

4.  Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.

Authors:  Paul D Williams; Charles R Owens; Jaroslaw Dziegielewski; Christopher A Moskaluk; Paul W Read; James M Larner; Michael D Story; William A Brock; Sally A Amundson; Jae K Lee; Dan Theodorescu
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

5.  Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

Authors:  Joshua R Porter; Brian E Fisher; Laura Baranello; Julia C Liu; Diane M Kambach; Zuqin Nie; Woo Seuk Koh; Ji Luo; Jayne M Stommel; David Levens; Eric Batchelor
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

6.  Distinct signaling pathways after higher or lower doses of radiation in three closely related human lymphoblast cell lines.

Authors:  Tzu-Pin Lu; Liang-Chuan Lai; Be-I Lin; Li-Han Chen; Tzu-Hung Hsiao; Howard L Liber; John A Cook; James B Mitchell; Mong-Hsun Tsai; Eric Y Chuang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

Review 7.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

8.  Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78.

Authors:  Jui-Ling Hsu; Po-Cheng Chiang; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11       Impact factor: 3.000

9.  Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.

Authors:  Yao Dai; Theodore S Lawrence; Liang Xu
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

10.  The scaffold protein TANK/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1.

Authors:  Wanqiao Zhang; Jian Wang; Ying Zhang; Yanzhi Yuan; Wei Guan; Chaozhi Jin; Hui Chen; Xiaohui Wang; Xiaoming Yang; Fuchu He
Journal:  Mol Biol Cell       Date:  2010-05-19       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.